Bristol James Arthur bought ERNA
February 7, 2025 · Form 4 insider transaction
Bristol James Arthur bought 72,074 shares of Ernexa Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
72,074
Price
$0.00
Total value
N/A
InsiderBristol James Arthur
RoleDirector
SecurityStock Option (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2025
Filing dateFebruary 10, 2025
Shares owned after72,074
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.